Advertisement
Advertisement
Astrotech Corporation (ASTC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.5300 |
| Open | 0.5400 |
| Bid | 0.5002 x 1200 |
| Ask | 0.5300 x 1000 |
| Day's Range | 0.5001 - 0.5450 |
| 52 Week Range | 0.4800 - 1.4000 |
| Volume | |
| Avg. Volume | 216,111 |
| Market Cap | 24.965M |
| Beta (5Y Monthly) | -1.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2360 |
| Earnings Date | Feb 14, 2022 - Feb 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results
AUSTIN, Texas, May 12, 2022--Astrotech Corporation reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.
- Business Wire
Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results
AUSTIN, Texas, February 11, 2022--Astrotech Corporation (Nasdaq: ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.
- Business Wire
Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as Its Chief Science Officer
AUSTIN, Texas, February 02, 2022--Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
